Madrigal's 15min chart triggers KDJ Golden Cross, Bullish Marubozu Formation.

According to the 15-minute chart of Madrigal, a significant bullish signal has been triggered, marked by the KDJ Golden Cross and a Bullish Marubozu pattern at 08/14/2025 13:00. This indicates that the momentum of the stock price is shifting in a positive direction, suggesting potential further price increases. Given the current control of buyers in the market, there is a strong likelihood of sustained bullish momentum.

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) has seen a significant bullish signal on its 15-minute chart, with a KDJ Golden Cross and a Bullish Marubozu pattern occurring at 08/14/2025 13:00. This technical indicator suggests that the momentum of the stock price is shifting positively, indicating potential for further price increases. Given the current dominance of buyers in the market, there is a strong likelihood of sustained bullish momentum [2].

Analysts have also upgraded their estimates for Madrigal Pharmaceuticals, reflecting increased optimism around the company's prospects. The latest consensus from 13 analysts is for revenues of US$874 million in 2025, representing a substantial 69% improvement in sales compared to the last 12 months. Losses are predicted to fall by 30% to US$8.91 per share [1]. Prior to this upgrade, analysts had forecasted revenues of US$682 million and losses of US$12.77 per share in 2025. The upgrades suggest a change in sentiment, with analysts administering a significant upgrade to this year's revenue estimates while reducing their loss estimates.

Despite these upgrades, analysts have not changed their price target of US$438, indicating that their latest estimates do not have a long-term impact on what they think the stock is worth. However, the analysts expect Madrigal Pharmaceuticals' growth to accelerate, with the forecast 187% annualized growth to the end of 2025 ranking favorably alongside historical growth of 100% per annum over the past five years. This growth outlook is brighter than the recent past and faster than the wider industry, which is forecast to grow its revenue by 19% annually [1].

Madrigal Pharmaceuticals' recent bullish trend, as indicated by technical indicators, suggests a positive outlook for the stock. However, investors should remain vigilant and consider the broader market conditions and potential risks. The cryptocurrency market, including Solana, has been volatile, with Solana's SOL token surging past $200 due to strong institutional buying [2]. This could impact the broader financial markets and potentially affect Madrigal Pharmaceuticals.

References:
[1] https://finance.yahoo.com/news/party-time-brokers-just-made-141608400.html
[2] https://www.ainvest.com/news/madrigal-15min-chart-triggers-kdj-golden-cross-bullish-marubozu-formation-2508-52/